These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Disassembly and reassembly of human papillomavirus virus-like particles produces more virion-like antibody reactivity. Zhao Q; Modis Y; High K; Towne V; Meng Y; Wang Y; Alexandroff J; Brown M; Carragher B; Potter CS; Abraham D; Wohlpart D; Kosinski M; Washabaugh MW; Sitrin RD Virol J; 2012 Feb; 9():52. PubMed ID: 22356831 [TBL] [Abstract][Full Text] [Related]
3. Stop codon mutagenesis for homogenous expression of human papillomavirus L1 protein in Escherichia coli. Wang D; Fan F; Li Z; Liu X; Song S; Wei S; He M; Lin Y; Li Z; Wei M; Yu H; Gu Y; Li S; Xia N Protein Expr Purif; 2017 May; 133():110-120. PubMed ID: 28267627 [TBL] [Abstract][Full Text] [Related]
4. Optimizing the secondary structure of human papillomavirus type 16 L1 mRNA enhances L1 protein expression in Saccharomyces cerevisiae. Kim HJ; Lee SJ; Kim HJ J Biotechnol; 2010 Oct; 150(1):31-6. PubMed ID: 20696192 [TBL] [Abstract][Full Text] [Related]
5. [Expression, purification and immunogenicity analysis of HPV type 18 virus-like particles from Escherichia coli]. Xie M; Li S; Shen W; Li Z; Zhuang Y; Mo X; Gu Y; Wu T; Zhang J; Xia N Sheng Wu Gong Cheng Xue Bao; 2009 Jul; 25(7):1082-7. PubMed ID: 19835152 [TBL] [Abstract][Full Text] [Related]
6. VLP Production from Recombinant L1/L2 HPV-16 Protein Expressed in Pichia Pastoris. Sanchooli A; Aghaiypour K; Kiasari BA; Samarbaf-Zadeh A; Ghadiri A; Makvandi M Protein Pept Lett; 2018; 25(8):783-790. PubMed ID: 30091403 [TBL] [Abstract][Full Text] [Related]
7. The L1 major capsid protein of human papillomavirus type 16 variants affects yield of virus-like particles produced in an insect cell expression system. Touze A; El Mehdaoui S; Sizaret PY; Mougin C; Muñoz N; Coursaget P J Clin Microbiol; 1998 Jul; 36(7):2046-51. PubMed ID: 9650960 [TBL] [Abstract][Full Text] [Related]
8. Equine papillomavirus type 1: complete nucleotide sequence and characterization of recombinant virus-like particles composed of the EcPV-1 L1 major capsid protein. Ghim SJ; Rector A; Delius H; Sundberg JP; Jenson AB; Van Ranst M Biochem Biophys Res Commun; 2004 Nov; 324(3):1108-15. PubMed ID: 15485669 [TBL] [Abstract][Full Text] [Related]
9. Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16. Varsani A; Williamson AL; de Villiers D; Becker I; Christensen ND; Rybicki EP J Virol; 2003 Aug; 77(15):8386-93. PubMed ID: 12857908 [TBL] [Abstract][Full Text] [Related]
10. Identification of a human papillomavirus type 16-specific epitope on the C-terminal arm of the major capsid protein L1. Carter JJ; Wipf GC; Benki SF; Christensen ND; Galloway DA J Virol; 2003 Nov; 77(21):11625-32. PubMed ID: 14557648 [TBL] [Abstract][Full Text] [Related]
11. Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles. Rose RC; Bonnez W; Reichman RC; Garcea RL J Virol; 1993 Apr; 67(4):1936-44. PubMed ID: 8383219 [TBL] [Abstract][Full Text] [Related]
12. An HPV 16 L1-based chimeric human papilloma virus-like particles containing a string of epitopes produced in plants is able to elicit humoral and cytotoxic T-cell activity in mice. Paz De la Rosa G; Monroy-García A; Mora-García Mde L; Peña CG; Hernández-Montes J; Weiss-Steider B; Gómez-Lim MA Virol J; 2009 Jan; 6():2. PubMed ID: 19126233 [TBL] [Abstract][Full Text] [Related]
13. Optimized production strategy of the major capsid protein HPV 16L1 non-assembly variant in E. coli. Roos N; Breiner B; Preuss L; Lilie H; Hipp K; Herrmann H; Horn T; Biener R; Iftner T; Simon C Protein Expr Purif; 2020 Nov; 175():105690. PubMed ID: 32681956 [TBL] [Abstract][Full Text] [Related]
14. N-terminal truncations on L1 proteins of human papillomaviruses promote their soluble expression in Escherichia coli and self-assembly in vitro. Wei M; Wang D; Li Z; Song S; Kong X; Mo X; Yang Y; He M; Li Z; Huang B; Lin Z; Pan H; Zheng Q; Yu H; Gu Y; Zhang J; Li S; Xia N Emerg Microbes Infect; 2018 Sep; 7(1):160. PubMed ID: 30254257 [TBL] [Abstract][Full Text] [Related]
15. Mutations on the FG surface loop of human papillomavirus type 16 major capsid protein affect recognition by both type-specific neutralizing antibodies and cross-reactive antibodies. Carpentier GS; Fleury MJ; Touzé A; Sadeyen JR; Tourne S; Sizaret PY; Coursaget P J Med Virol; 2005 Dec; 77(4):558-65. PubMed ID: 16254978 [TBL] [Abstract][Full Text] [Related]
16. Increasing the expression levels of papillomavirus major capsid protein in Escherichia coli by N-terminal deletion. Ma Z; Chen B; Zhang F; Yu M; Liu T; Liu L Protein Expr Purif; 2007 Nov; 56(1):72-9. PubMed ID: 17616400 [TBL] [Abstract][Full Text] [Related]
17. Production of human papillomavirus type 16 L1 virus-like particles by recombinant Lactobacillus casei cells. Aires KA; Cianciarullo AM; Carneiro SM; Villa LL; Boccardo E; Pérez-Martinez G; Perez-Arellano I; Oliveira ML; Ho PL Appl Environ Microbiol; 2006 Jan; 72(1):745-52. PubMed ID: 16391114 [TBL] [Abstract][Full Text] [Related]
18. Production of human papillomavirus type 33 L1 major capsid protein and virus-like particles from Bacillus subtilis to develop a prophylactic vaccine against cervical cancer. Baek JO; Seo JW; Kwon O; Park SM; Kim CH; Kim IH Enzyme Microb Technol; 2012 Mar; 50(3):173-80. PubMed ID: 22305172 [TBL] [Abstract][Full Text] [Related]
19. Efficient production of chimeric human papillomavirus 16 L1 protein bearing the M2e influenza epitope in Nicotiana benthamiana plants. Matić S; Rinaldi R; Masenga V; Noris E BMC Biotechnol; 2011 Nov; 11():106. PubMed ID: 22085463 [TBL] [Abstract][Full Text] [Related]